A transfected cell model for the renal toxin transporter, rOCT2

Area of Science:

• Pharmacology
• Molecular Biology
• Renal Physiology

Background:

• Organic cation transporters (OCTs) play a crucial role in the transport of endogenous compounds and xenobiotics.
• Understanding the function and substrate specificity of specific OCTs, like rat OCT2 (rOCT2), is vital for drug development and understanding renal secretion.

Purpose of the Study:

• To establish a stable cell line expressing rat organic cation transporter 2 (rOCT2) for functional studies.
• To characterize the transport properties and substrate specificity of rOCT2.
• To investigate the potential role of rOCT2 in the renal secretion of drugs, including cisplatin.

Main Methods:

• Insertion of rat OCT2 cDNA into the pLXSN retroviral plasmid.
• Stable transfection of NIH3T3 cells with the rOCT2-expressing plasmid.
• Measurement of tetraethylammonium (TEA) uptake and efflux in transfected cells.
• Inhibition studies using known OCT inhibitors and potential drug substrates.

Main Results:

• Transfected NIH3T3 cells demonstrated significantly enhanced tetraethylammonium (TEA) uptake and efflux compared to wild-type cells.
• TEA uptake was temperature-dependent and inhibited by low extracellular pH, suggesting proton cotransport.
• Cisplatin competitively inhibited TEA uptake by rOCT2, indicating a potential role in cisplatin renal secretion.
• Daunomycin, vinblastine, and deoxyadenosine analogs were not substrates for rOCT2.

Conclusions:

• Stable NIH3T3 cell lines expressing rOCT2 provide a valuable system for studying organic ion transporter function.
• rOCT2 exhibits specific substrate preferences and is inhibited by certain compounds, including cisplatin.
• These findings suggest rOCT2 may be involved in the renal transport of cisplatin.